Seed · Industrial tech
NuSynth raises ₹36.5 crore to develop chemical process technology
Avaana Capital and Shastra VC co-lead the seed financing.
NuSynth’s initial markets are pharmaceutical and electronic chemicals, where difficult synthesis routes can make production costly and dependent on specialized inputs. The company is building proprietary process technology that manufacturers can use at commercial scale.
Its model combines in-house research with external manufacturing capacity. That lets the team focus on developing and validating new chemistry while working with existing plants to produce the resulting chemicals, rather than constructing a manufacturing network from scratch.
Use of funds
Develop R&D technology and proprietary chemical processes.
Build scale-up capabilities and expand the team.
Funding history
Seed · This round₹365M